Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

BET Inhibitors in Chronic Lymphocytic Leukemia: JQ1 Synergizes with Venetoclax in Promoting Apoptosis

Giovanna Carrà, PhDstudent, Cristina Panuzzo, Deborah Morena, Marcello Francesco Lingua, PhDstudent, Cristina Fantino, Mara Brancaccio, Giuseppe Saglio, MD PhD, Angelo Guerrasio, MD, Riccardo Taulli, Alessandro Morotti, MD PhD

Blood (2017) 130 (Supplement 1): 2542.

https://doi.org/10.1182/blood.V130.Suppl_1.2542.2542

Published: 2017

Journal Articles

Morgana acts as an oncosuppressor in chronic myeloid leukemia

Blood (2015) 125 (14): 2245–2253.

https://doi.org/10.1182/blood-2014-05-575001

Published: 2015

Includes: Supplemental data

Journal Articles

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

Blood (2015) 125 (3): 499–503.

https://doi.org/10.1182/blood-2014-06-579466

Published: 2015

Includes: Supplemental data

Journal Articles

Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia

Blood (2014) 124 (21): 2212.

https://doi.org/10.1182/blood.V124.21.2212.2212

Published: 2014

Journal Articles

Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients

Valentina Rosso, PhD, Cristina Panuzzo, PhD, Enrico Bracco, PhD, Sonia Carturan, PhD, Valentina Campia, PhD, Alessandra Favole, PhD, Elisabetta Signorino, PhD, Pimjai Niparuk, MD, Chiara Calabrese, PhD, Luciana De Luca, MD, Antonella Caivano, Annalisa Morano, Francesco Frassoni, Giuseppe Saglio, MD, Daniela Cilloni, MD

Blood (2012) 120 (21): 4616.

https://doi.org/10.1182/blood.V120.21.4616.4616

Published: 2012

Journal Articles

Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors.

Daniela Cilloni, MD, PhD, Francesca Pellicano, PhD, Vignir G Helgason, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Brian J Huntly, MD, Elaine Allan, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Giuseppe Saglio, MD, Tessa L Holyoake, MD

Blood (2009) 114 (22): 187.

https://doi.org/10.1182/blood.V114.22.187.187

Published: 2009

Journal Articles

The Oncogenic Kinase Bcr-Abl Directly Regulates Splicing of BclX through a Quaternary Complex Coordinated by Nck-Beta and Sam-68 Adapter Proteins.

Bracco Enrico, Valentina Rosso, Mussino Stefano, Francesca Arruga, Sonia Carturan, PhD, Francesca Messa, PhD, Cristina Panuzzo, PhD, Marco Lo Iacono, Paolo Nicoli, MD, Emanuela Messa, MD, Antonia Rotolo, Monica Pradotto, PhD, Alessandro Morotti, MD, Alessandra Balbo, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Daniela Cilloni, MD, PhD, Giuseppe Saglio, MD

Blood (2009) 114 (22): 2171.

https://doi.org/10.1182/blood.V114.22.2171.2171

Published: 2009

Journal Articles

The Non Receptor Transmembrane Tyrosine Kinase STYK1 Represents a Novel Lymphocyte Marker, Whose Expression Is Deregulated in Leukemia, and a Potential Molecular Druggable Target

Blood (2008) 112 (11): 5334.

https://doi.org/10.1182/blood.V112.11.5334.5334

Published: 2008

Journal Articles

Single Base Pair Mutation Detection by PNA Direct PCR Clamping: Application to Bcr-Abl T315I Mutation

Blood (2008) 112 (11): 4224.

https://doi.org/10.1182/blood.V112.11.4224.4224

Published: 2008

Journal Articles

Imatinib Induced Re-Activation of FoxO3 Transcription Factor in CML Is Responsible for the Induction of a Quiescent Status of CD34 Leukaemic Progenitor Cells.

Daniela Cilloni, MD, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Roberto Bernardoni, PhD, Sonia Carturan, PhD, Marisa Pautasso, MD, Emanuela Messa, MD, Alessandro Morotti, MD, Monica Pradotto, PhD, Ilaria Iacobucci, Thea Kalebic, MD, Giovanni Martinelli, MD, Giuseppe Saglio, MD

Blood (2008) 112 (11): 1090.

https://doi.org/10.1182/blood.V112.11.1090.1090

Published: 2008

Journal Articles

Identification of Genes Sustaining Bcr-Abl Oncogenic Signalling and CML Progression through a Genetic Tool Based on Human Bcr-Abl Transgenic Drosophila Melanogaster.

Daniela Cilloni, Francesca Messa, PhD, Roberto Bernardoni, PhD, Francesca Arruga, PhD, Monica Pradotto, PhD, Enrico Bracco, PhD, Cristina Panuzzo, PhD, Chiara Maffè, PhD, Emanuela Messa, MD, Ilaria Iacobucci, Thea Kalebic, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Giuseppe Saglio, MD

Blood (2008) 112 (11): 1091.

https://doi.org/10.1182/blood.V112.11.1091.1091

Published: 2008

Journal Articles

Nck Beta Adapter Protein Coordinates Bcr-Abl/Sam68 Intermolecular Interaction.

Enrico Bracco, PhD, Erika Deklic, Valentina Rosso, Stefano Mussino, PhD, Francesca Arruga, PhD, Sonia Carturan, PhD, Francesca Messa, PhD, Ilaria Defilippi, PhD, Cristina Panuzzo, PhD, Paolo Nicoli, Emanuela Messa, MD, Antonia Rotolo, Roberto Pedrola, Alessandro Morotti, MD, Alessandra Balbo, Ilaria Iacobucci, PhD, Giovanni Martinelli, Daniela Cilloni, Giuseppe Saglio

Blood (2008) 112 (11): 1093.

https://doi.org/10.1182/blood.V112.11.1093.1093

Published: 2008

Journal Articles

The Re-Activation of FoxO3 Transcription Factor in Acute Myeloid Leukaemia Is Responsible for the Induction of a Quiescent Status of Leukaemic Progenitor Cells.

Daniela Cilloni, Cristina Panuzzo, PhD, Francesca Arruga, PhD, Francesca Messa, PhD, Monica Pradotto, PhD, Enrico Bracco, PhD, Alessandro Morotti, MD, Emanuela Messa, Antonia Rotolo, Ilaria Iacobucci, Chiara Marrè, Marisa Pautasso, Giovanni Martinelli, MD, Giuseppe Saglio

Blood (2008) 112 (11): 929.

https://doi.org/10.1182/blood.V112.11.929.929

Published: 2008

Journal Articles

FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.

Daniela Cilloni, MD, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Paolo Nicoli, MD, Emanuela Messa, MD, Stefano Ulisciani, MD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Thea Kalebic, MD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 1010.

https://doi.org/10.1182/blood.V110.11.1010.1010

Published: 2007

Journal Articles

FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.

Daniela Cilloni, MD, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Paolo Nicoli, MD, Emanuela Messa, MD, Sonia Carturan, PhD, Ilaria Defilippi, PhD, Ilaria Iacobucci, PhD, Valentina Rosso, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 1251.

https://doi.org/10.1182/blood.V110.11.1251.1251

Published: 2007

NARROW

BET Inhibitors in Chronic Lymphocytic Leukemia: JQ1 Synergizes with Venetoclax in Promoting Apoptosis

Morgana acts as an oncosuppressor in chronic myeloid leukemia

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia

Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients

Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors.

The Oncogenic Kinase Bcr-Abl Directly Regulates Splicing of BclX through a Quaternary Complex Coordinated by Nck-Beta and Sam-68 Adapter Proteins.

The Non Receptor Transmembrane Tyrosine Kinase STYK1 Represents a Novel Lymphocyte Marker, Whose Expression Is Deregulated in Leukemia, and a Potential Molecular Druggable Target

Single Base Pair Mutation Detection by PNA Direct PCR Clamping: Application to Bcr-Abl T315I Mutation

Imatinib Induced Re-Activation of FoxO3 Transcription Factor in CML Is Responsible for the Induction of a Quiescent Status of CD34 Leukaemic Progenitor Cells.

Identification of Genes Sustaining Bcr-Abl Oncogenic Signalling and CML Progression through a Genetic Tool Based on Human Bcr-Abl Transgenic Drosophila Melanogaster.

Nck Beta Adapter Protein Coordinates Bcr-Abl/Sam68 Intermolecular Interaction.

The Re-Activation of FoxO3 Transcription Factor in Acute Myeloid Leukaemia Is Responsible for the Induction of a Quiescent Status of Leukaemic Progenitor Cells.

FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.

FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only